<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38932201</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>04</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Coxsackievirus A7 and Enterovirus A71 Significantly Reduce SARS-CoV-2 Infection in Cell and Animal Models.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">909</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16060909</ELocationID><Abstract><AbstractText>In this study, we investigated the features of co-infection with SARS-CoV-2 and the enterovirus vaccine strain LEV8 of coxsackievirus A7 or enterovirus A71 for Vero E6 cells and Syrian hamsters. The investigation of co-infection with SARS-CoV-2 and LEV-8 or EV-A71 in the cell model showed that a competitive inhibitory effect for these viruses was especially significant against SARS-CoV-2. Pre-infection with enteroviruses in the animals caused more than a 100-fold decrease in the levels of SARS-CoV-2 virus replication in the respiratory tract and more rapid clearance of infectious SARS-CoV-2 from the lower respiratory tract. Co-infection with SARS-CoV-2 and LEV-8 or EV-A71 also reduced the severity of clinical manifestations of the SARS-CoV-2 infection in the animals. Additionally, the histological data illustrated that co-infection with strain LEV8 of coxsackievirus A7 decreased the level of pathological changes induced by SARS-CoV-2 in the lungs. Research into the chemokine/cytokine profile demonstrated that the studied enteroviruses efficiently triggered this part of the antiviral immune response, which is associated with the significant inhibition of SARS-CoV-2 infection. These results demonstrate that there is significant viral interference between the studied strain LEV-8 of coxsackievirus A7 or enterovirus A71 and SARS-CoV-2 in vitro and in vivo.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Svyatchenko</LastName><ForeName>Victor A</ForeName><Initials>VA</Initials><Identifier Source="ORCID">0000-0002-2729-0592</Identifier><AffiliationInfo><Affiliation>State Research Center of Virology and Biotechnology "Vector", Koltsovo 630559, Novosibirsk Region, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legostaev</LastName><ForeName>Stanislav S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0002-6202-445X</Identifier><AffiliationInfo><Affiliation>State Research Center of Virology and Biotechnology "Vector", Koltsovo 630559, Novosibirsk Region, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lutkovskiy</LastName><ForeName>Roman Y</ForeName><Initials>RY</Initials><AffiliationInfo><Affiliation>State Research Center of Virology and Biotechnology "Vector", Koltsovo 630559, Novosibirsk Region, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Protopopova</LastName><ForeName>Elena V</ForeName><Initials>EV</Initials><Identifier Source="ORCID">0000-0002-2782-8364</Identifier><AffiliationInfo><Affiliation>State Research Center of Virology and Biotechnology "Vector", Koltsovo 630559, Novosibirsk Region, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ponomareva</LastName><ForeName>Eugenia P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>State Research Center of Virology and Biotechnology "Vector", Koltsovo 630559, Novosibirsk Region, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omigov</LastName><ForeName>Vladimir V</ForeName><Initials>VV</Initials><Identifier Source="ORCID">0000-0002-2028-6099</Identifier><AffiliationInfo><Affiliation>State Research Center of Virology and Biotechnology "Vector", Koltsovo 630559, Novosibirsk Region, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taranov</LastName><ForeName>Oleg S</ForeName><Initials>OS</Initials><Identifier Source="ORCID">0000-0002-6746-8092</Identifier><AffiliationInfo><Affiliation>State Research Center of Virology and Biotechnology "Vector", Koltsovo 630559, Novosibirsk Region, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ternovoi</LastName><ForeName>Vladimir A</ForeName><Initials>VA</Initials><Identifier Source="ORCID">0000-0003-1275-171X</Identifier><AffiliationInfo><Affiliation>State Research Center of Virology and Biotechnology "Vector", Koltsovo 630559, Novosibirsk Region, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agafonov</LastName><ForeName>Alexander P</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0003-2577-0434</Identifier><AffiliationInfo><Affiliation>State Research Center of Virology and Biotechnology "Vector", Koltsovo 630559, Novosibirsk Region, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loktev</LastName><ForeName>Valery B</ForeName><Initials>VB</Initials><Identifier Source="ORCID">0000-0002-0229-321X</Identifier><AffiliationInfo><Affiliation>State Research Center of Virology and Biotechnology "Vector", Koltsovo 630559, Novosibirsk Region, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008647" MajorTopicYN="Y">Mesocricetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Syrian hamster</Keyword><Keyword MajorTopicYN="N">co-infection</Keyword><Keyword MajorTopicYN="N">coxsackievirus A7</Keyword><Keyword MajorTopicYN="N">enterovirus A71</Keyword></KeywordList><CoiStatement>No authors report any conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38932201</ArticleId><ArticleId IdType="pmc">PMC11209502</ArticleId><ArticleId IdType="doi">10.3390/v16060909</ArticleId><ArticleId IdType="pii">v16060909</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G., Hu Y., Tao Z., Tian J., Pei Y., et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–269. doi: 10.1038/s41586-020-2008-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–473. doi: 10.1016/S0140-6736(20)30185-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30185-9</ArticleId><ArticleId IdType="pmc">PMC7135038</ArticleId><ArticleId IdType="pubmed">31986257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Quinn J., Pinsky B., Shah N.H., Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323:2085–2086. doi: 10.1001/jama.2020.6266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6266</ArticleId><ArticleId IdType="pmc">PMC7160748</ArticleId><ArticleId IdType="pubmed">32293646</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury L., Lim B., Baskaran V., Lim W. Co-infections in people with COVID-19: A systematic review and meta-analysis. J. Infect. 2020;81:266–275. doi: 10.1016/j.jinf.2020.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.046</ArticleId><ArticleId IdType="pmc">PMC7255350</ArticleId><ArticleId IdType="pubmed">32473235</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass E., Hoang V., Boschi C., Ninove L., Zandotti C., Boutin A., Bremond V., Dubourg G., Ranque S., Lagier J., et al. Incidence and outcome of coinfections with SARS-CoV-2 and rhinovirus. Viruses. 2021;13:2528. doi: 10.3390/v13122528.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13122528</ArticleId><ArticleId IdType="pmc">PMC8709236</ArticleId><ArticleId IdType="pubmed">34960797</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou H., Paranikolopoulou A., Vassiliu S., Theodoridou K., Nikolopolou G., Sipsas N. COVID-19 and respiratory virus co-Infections: A systematic review of the literature. Viruses. 2023;15:865. doi: 10.3390/v15040865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040865</ArticleId><ArticleId IdType="pmc">PMC10142898</ArticleId><ArticleId IdType="pubmed">37112844</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg E., Hasegawa K., Lawrence A., Kline J., Camargo C. Viral coinfection is associated with improved outcomes in emergency department patients with SARS-CoV-2. West. J. Emerg. Med. 2021;22:1262–1269. doi: 10.5811/westjem.2021.8.53590.</Citation><ArticleIdList><ArticleId IdType="doi">10.5811/westjem.2021.8.53590</ArticleId><ArticleId IdType="pmc">PMC8597701</ArticleId><ArticleId IdType="pubmed">34787549</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J., Zhang A., Yuan S., Poon V., Chan C., Lee A., Chan W., Fan Z., Tsoi H., Wen L., et al. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden Syrian hamster model: Implications for disease pathogenesis and transmissibility. Clin. Infect. Dis. 2020;71:2428–2446. doi: 10.1093/cid/ciaa325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa325</ArticleId><ArticleId IdType="pmc">PMC7184405</ArticleId><ArticleId IdType="pubmed">32215622</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai M., Iwatsuki-Horimoto K., Hatta M., Loeber S., Halfmann P.J., Nakajima N., Watanabe T., Ujie M., Takahashi M. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc. Natl. Acad. Sci. USA. 2020;117:16587–16595. doi: 10.1073/pnas.2009799117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2009799117</ArticleId><ArticleId IdType="pmc">PMC7368255</ArticleId><ArticleId IdType="pubmed">32571934</ArticleId></ArticleIdList></Reference><Reference><Citation>Phyu W., Ong K., Won K. A consistent orally-infected hamster model for enterovirus A71 encephalomyelitis demonstrates squamous lesions in the paws, skin and oral cavity reminiscent of Hand-Foot-and-Mouth Disease. PLoS ONE. 2016;11:e0147463. doi: 10.1371/journal.pone.0147463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0147463</ArticleId><ArticleId IdType="pmc">PMC4729525</ArticleId><ArticleId IdType="pubmed">26815859</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M.P., Voroshilova M.K., Antsupova A.S., Boiko V.M., Blinova M.I., Priimiagi L.S., Rodin V.I., Seibil V.B., Siniak K.M., Smorodintsev A.A. Live enteroviral vaccines for the emergency nonspecific prevention of mass respiratory diseases during fall-winter epidemics of influenza and acute respiratory diseases. Zhurnal Mikrobiol. Epidemiol. Immunobiol. 1992;11–12:37–40.</Citation><ArticleIdList><ArticleId IdType="pubmed">1338742</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto T. Hand-Foot-and-Mouth Disease, Aseptic Meningitis, and Encephalitis Caused by Enterovirus. Brain Nerve. 2018;70:121–131. doi: 10.11477/mf.1416200964.</Citation><ArticleIdList><ArticleId IdType="doi">10.11477/mf.1416200964</ArticleId><ArticleId IdType="pubmed">29433113</ArticleId></ArticleIdList></Reference><Reference><Citation>Svyatchenko V., Nikonov S., Mayorov A., Gelfond M., Loktev V. Antiviral photodynamic therapy: Inactivation and inhibition of SARS-CoV-2 in vitro using methylene blue and Radachlorin. Photodiagnosis Photodyn. Ther. 2021;33:102–112. doi: 10.1016/j.pdpdt.2020.102112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2020.102112</ArticleId><ArticleId IdType="pmc">PMC7690324</ArticleId><ArticleId IdType="pubmed">33249118</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth K., Spencer J., Dhar D., Sagartz J., Buller R., Painter G., Wold W.S. Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus induced mortality in a permissive, immunosuppressed animal model. Proc. Natl. Acad. Sci. USA. 2008;105:7293–7297. doi: 10.1073/pnas.0800200105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0800200105</ArticleId><ArticleId IdType="pmc">PMC2438243</ArticleId><ArticleId IdType="pubmed">18490659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryzhikov A.B., Ryzhikov E.A., Bogryantseva M.P., Danilenko E.D., Imatdinov I.R., Nechaeva E.A., Pyankov O., Pyankova O.G., Susloparov I., Taranov O., et al. Immunogenicity and protectivity of the peptide vaccine against SARS-CoV-2. Ann. Russ. Acad. Med. Sci. 2021;76:5–19. doi: 10.15690/vramn1528.</Citation><ArticleIdList><ArticleId IdType="doi">10.15690/vramn1528</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders R., Mason D.J., Foy C.A., Huggett J.F. Evaluation of digital PCR for absolute RNA quantification. PLoS ONE. 2013;8:e75296. doi: 10.1371/journal.pone.0075296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075296</ArticleId><ArticleId IdType="pmc">PMC3779174</ArticleId><ArticleId IdType="pubmed">24073259</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J.F., Yuan S., Zhang A., Poon V.K., Chan C.C., Lee A.C., Fan Z., Li C., Liang R., Cao J. Surgical mask partition reduces the risk of noncontact transmission in a Golden Syrian hamster model for coronavirus disease 2019 (COVID-19) Clin. Infect. Dis. 2020;71:2139–2149. doi: 10.1093/cid/ciaa644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa644</ArticleId><ArticleId IdType="pmc">PMC7314229</ArticleId><ArticleId IdType="pubmed">32472679</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemi S.A., Safamanesh S., Ghasemzadeh-Moghaddam H., Ghafouri M., Azimian A. High prevalence of SARS-CoV-2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran. J. Med. Virol. 2020;93:1008–1012. doi: 10.1002/jmv.26364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26364</ArticleId><ArticleId IdType="pubmed">32720703</ArticleId></ArticleIdList></Reference><Reference><Citation>Stowe J., Tessier E., Zhao H., Guy R., Muller-Pebody B., Zambon M., Andrews N., Ramsay M., Lopez Bernal J. Interactions between SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: A test negative design. Int. J. Epidemiol. 2021;50:1124–1133. doi: 10.1093/ije/dyab081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab081</ArticleId><ArticleId IdType="pmc">PMC8135706</ArticleId><ArticleId IdType="pubmed">33942104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N., Sharma S., Barua S., Tripathi B., Rouse B. Virological and Immunological Outcomes of Coinfections. Clin. Microbiol. Rev. 2018;31:e00111-17. doi: 10.1128/CMR.00111-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00111-17</ArticleId><ArticleId IdType="pmc">PMC6148187</ArticleId><ArticleId IdType="pubmed">29976554</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai L., Zhao Y., Dong J., Liang S., Guo M., Liu X., Wang X., Huang Z., Sun X., Zhang Z., et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res. 2021;4:395–403. doi: 10.1038/s41422-021-00473-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00473-1</ArticleId><ArticleId IdType="pmc">PMC7890106</ArticleId><ArticleId IdType="pubmed">33603116</ArticleId></ArticleIdList></Reference><Reference><Citation>Svyatchenko V.A., Ternovoi V.A., Lutkovskiy R.Y., Protopopova E.V., Gudymo A.S., Danilchenko N.V., Susloparov I.M., Kolosova N.P., Ryzhikov A.B., Taranov O.S., et al. Human Adenovirus and Influenza A Virus Exacerbate SARS-CoV-2 Infection in Animal Models. Microorganisms. 2023;11:180. doi: 10.3390/microorganisms11010180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11010180</ArticleId><ArticleId IdType="pmc">PMC9860643</ArticleId><ArticleId IdType="pubmed">36677472</ArticleId></ArticleIdList></Reference><Reference><Citation>Essaidi-Laziosi M., Alvarez C., Puhach O., Sattonnet-Roche P., Torriani G., Tapparel C., Kaiser L., Eckerle I. Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract. Emerg. Microbes Infect. 2022;11:412–423. doi: 10.1080/22221751.2021.2021806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.2021806</ArticleId><ArticleId IdType="pmc">PMC8803056</ArticleId><ArticleId IdType="pubmed">34931581</ArticleId></ArticleIdList></Reference><Reference><Citation>Fage C., Henaut M., Carbonneau J., Piret J., Boivin G. Influenza A(H1N1)pdm09 virus but not respiratory syncytial virus interferes with SARS-CoV-2 replication during sequential infections in human nasal epithelial cells. Viruses. 2022;14:395. doi: 10.3390/v14020395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14020395</ArticleId><ArticleId IdType="pmc">PMC8879759</ArticleId><ArticleId IdType="pubmed">35215988</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston L., Tapparel C. Rhinoviruses and respiratory enteroviruses: Not as simple as ABC. Viruses. 2016;8:16. doi: 10.3390/v8010016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8010016</ArticleId><ArticleId IdType="pmc">PMC4728576</ArticleId><ArticleId IdType="pubmed">26761027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovesdi I., Sandig V., Slavin S., Renz W., Ranst M., Chumakov P., Bakacs T. The clinically validated viral superinfection therapy (SIT) platform technology could cure early cases of COVID-19 disease. Preprints. 2020:2020020147. doi: 10.20944/preprints202002.0147.v4.</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202002.0147.v4</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov K., Benn C.S., Aaby P., Kottilil S., Gallo R. Can existing live vaccines prevent COVID-19? Science. 2020;368:1187–1188. doi: 10.1126/science.abc4262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc4262</ArticleId><ArticleId IdType="pubmed">32527819</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashir J., AlKattan K., Yaqinuddin A. COVID-19: Cross-immunity of viral epitopes may influence severity of infection and immune response. Signal Transduct. Target. Ther. 2021;6:102. doi: 10.1038/s41392-021-00490-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00490-x</ArticleId><ArticleId IdType="pmc">PMC7919252</ArticleId><ArticleId IdType="pubmed">33649300</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrock E., Fujimura E., Kula T., Timms R., Lee I., Leng Y., Robinson M., Sie B., Li M. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science. 2020;370:eabd4250. doi: 10.1126/science.abd4250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4250</ArticleId><ArticleId IdType="pmc">PMC7857405</ArticleId><ArticleId IdType="pubmed">32994364</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber A.D., Osterrieder N., Bertzbach L.D., Vladimirova D., Greuel S., Ihlow J., Horst D., Trimpert J., Dietert K. Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2-infected Hamsters: What Matters? Am. J. Respir. Cell Mol. Biol. 2020;63:856–859. doi: 10.1165/rcmb.2020-0280LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2020-0280LE</ArticleId><ArticleId IdType="pmc">PMC7790148</ArticleId><ArticleId IdType="pubmed">32897757</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>